• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高分辨率计算机断层扫描上纤维化间质性肺异常的预测因素:一项前瞻性观察研究。

Predictive factors of fibrotic interstitial lung abnormality on high-resolution computed tomography scans: a prospective observational study.

作者信息

Ichikado Kazuya, Ichiyasu Hidenori, Iyonaga Kazuhiro, Kawamura Kodai, Yasuda Yuko, Anan Keisuke, Okabayashi Hiroko, Akaike Kimitaka, Higashi Noritaka, Johkoh Takeshi, Fujimoto Kiminori, Saito Tetsuo, Morinaga Jun, Yoshida Minoru, Mitsuzaki Katsuhiko, Sakagami Takuro

机构信息

Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, 5-3-1 Chikami, Chu-oh Ku, Kumamoto, 861-4101, Japan.

Department of Respiratory Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto 1-1-1 Honjo, Chuo-ku, 860-8556, Japan.

出版信息

BMC Pulm Med. 2025 Jan 29;25(1):47. doi: 10.1186/s12890-025-03520-4.

DOI:10.1186/s12890-025-03520-4
PMID:39881354
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11780992/
Abstract

BACKGROUND

Fibrotic types of interstitial lung abnormalities seen on high-resolution computed tomography scans, characterised by traction bronchiolectasis/bronchiectasis with or without honeycombing, are predictors of progression and poor prognostic factors of interstitial lung abnormalities. There are no reports on the clinical characteristics of fibrotic interstitial lung abnormalities on high-resolution computed tomography scans. Therefore, we aimed to examine these clinical characteristics and clarify the predictive factors of fibrotic interstitial lung abnormalities on high-resolution computed tomography scans.

METHODS

Clinical and paraclinical data of 164 patients enrolled in the initial year of a multicentre prospective observational study (Kumamoto interstitial lung abnormalities study in Japan) involving over 62,000 examinees during routine health examinations were analysed. Clinical laboratory evaluations are expressed as medians and interquartile ranges for each evaluation time point, and boxplots were created for graphical representation. The percentages of abnormal clinical laboratory results were compared between the groups using chi-square or Fisher's exact tests. Univariate or multivariate logistic regression analyses were performed to analyse the relationship between fibrotic interstitial lung abnormalities and other clinical factors.

RESULTS

Fibrotic interstitial lung abnormalities were observed on high-resolution computed tomography scans in 135 (82%) patients at the time of diagnosis. Multivariate analysis showed that older age (Odds ratio, 1.06; 95% confidence interval, 1.01-1.12; p = 0.021), auscultatory fine crackles (Odds ratio, 3.39; 95% confidence interval, 1.33-8.65; p < 0.01), and elevated serum surfactant protein-D (Odds ratio, 2.68; 95% confidence interval, 1.02-8.64; p = 0.045) were independent predictive factors of fibrotic interstitial lung abnormalities. The predicted area under the curve of the fibrotic interstitial lung abnormalities based on these three factors was 0.77 (95% confidence interval, 0.68-0.86). The proportion of undecided diagnoses in the fibrotic interstitial lung abnormalities group (14%) was significantly lower than that in the non-fibrotic interstitial lung abnormalities group (41%) (p = 0.0027).

CONCLUSIONS

Fine crackles on auscultation and elevated serum surfactant protein-D levels are predictors of fibrotic interstitial lung abnormalities in older patients with interstitial lung abnormalities. These findings may assist non-radiological physicians in referring patients to specialists for early intervention in progressive fibrotic interstitial lung diseases.

TRIAL REGISTRATION NUMBER/DATE: UMIN000045149/2021.12.1.

摘要

背景

在高分辨率计算机断层扫描中可见的纤维化型间质性肺异常,其特征为牵拉性细支气管扩张/支气管扩张伴或不伴蜂窝状改变,是间质性肺异常进展的预测指标和不良预后因素。目前尚无关于高分辨率计算机断层扫描中纤维化间质性肺异常临床特征的报道。因此,我们旨在研究这些临床特征,并阐明高分辨率计算机断层扫描中纤维化间质性肺异常的预测因素。

方法

分析了一项多中心前瞻性观察研究(日本熊本县间质性肺异常研究)首年纳入的164例患者的临床和辅助临床数据,该研究在常规健康检查期间对超过62000名受检者进行了调查。临床实验室评估结果以每个评估时间点的中位数和四分位间距表示,并绘制箱线图进行图形展示。使用卡方检验或Fisher精确检验比较各组异常临床实验室结果的百分比。进行单因素或多因素逻辑回归分析,以分析纤维化间质性肺异常与其他临床因素之间的关系。

结果

诊断时,135例(82%)患者的高分辨率计算机断层扫描显示存在纤维化间质性肺异常。多因素分析显示,年龄较大(比值比,1.06;95%置信区间,1.01 - 1.12;p = 0.021)、听诊闻及细湿啰音(比值比,3.39;95%置信区间,1.33 - 8.65;p < 0.01)和血清表面活性蛋白-D升高(比值比,2.68;95%置信区间,1.02 - 8.64;p = 0.045)是纤维化间质性肺异常的独立预测因素。基于这三个因素的纤维化间质性肺异常预测曲线下面积为0.77(95%置信区间,0.68 - 0.86)。纤维化间质性肺异常组中诊断不明确的比例(14%)显著低于非纤维化间质性肺异常组(41%)(p = 0.0027)。

结论

听诊闻及细湿啰音和血清表面活性蛋白-D水平升高是老年间质性肺异常患者纤维化间质性肺异常的预测指标。这些发现可能有助于非放射科医生将患者转诊给专科医生,以便对进行性纤维化间质性肺疾病进行早期干预。

试验注册号/日期:UMIN000045149/2021.12.1

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8600/11780992/0cdbf88d7993/12890_2025_3520_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8600/11780992/d4ab1aaee74c/12890_2025_3520_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8600/11780992/69a335e81fd7/12890_2025_3520_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8600/11780992/0cdbf88d7993/12890_2025_3520_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8600/11780992/d4ab1aaee74c/12890_2025_3520_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8600/11780992/69a335e81fd7/12890_2025_3520_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8600/11780992/0cdbf88d7993/12890_2025_3520_Fig3_HTML.jpg

相似文献

1
Predictive factors of fibrotic interstitial lung abnormality on high-resolution computed tomography scans: a prospective observational study.高分辨率计算机断层扫描上纤维化间质性肺异常的预测因素:一项前瞻性观察研究。
BMC Pulm Med. 2025 Jan 29;25(1):47. doi: 10.1186/s12890-025-03520-4.
2
Dynamics of interstitial lung disease following immunosuppressive treatment differ between antisynthetase syndrome and systemic sclerosis.免疫抑制治疗后间质性肺疾病的动态变化在抗合成酶综合征和系统性硬化症之间存在差异。
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251336896. doi: 10.1177/17534666251336896. Epub 2025 May 8.
3
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.环磷酰胺用于治疗结缔组织病相关的间质性肺疾病。
Cochrane Database Syst Rev. 2018 Jan 3;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2.
4
Prevalence and clinical features of progressive pulmonary fibrosis in patients with unclassifiable idiopathic interstitial pneumonia: A post hoc analysis of prospective multicenter registry.无法分类的特发性间质性肺炎患者中进行性肺纤维化的患病率及临床特征:一项前瞻性多中心注册研究的事后分析
Respir Investig. 2025 Mar;63(2):216-223. doi: 10.1016/j.resinv.2025.01.007. Epub 2025 Jan 31.
5
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
6
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
7
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
8
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).远程医疗干预:针对慢性阻塞性肺疾病(COPD)患者的远程监测和咨询。
Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196. doi: 10.1002/14651858.CD013196.pub2.
9
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.噻托溴铵与长效β受体激动剂治疗稳定期慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009157. doi: 10.1002/14651858.CD009157.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

本文引用的文献

1
Multidisciplinary teams in the clinical care of fibrotic interstitial lung disease: current perspectives.纤维化间质性肺疾病临床护理中的多学科团队:当前观点
Eur Respir Rev. 2022 Sep 7;31(165). doi: 10.1183/16000617.0003-2022. Print 2022 Sep 30.
2
Progressive Pulmonary Fibrosis and Interstitial Lung Abnormalities: Expert Panel Narrative Review.进行性肺纤维化和间质性肺异常:专家小组叙述性综述
AJR Am J Roentgenol. 2025 Mar;224(3):e2431125. doi: 10.2214/AJR.24.31125. Epub 2024 Apr 24.
3
Prevalence, Risk Factors, and Outcomes of Adult Interstitial Lung Abnormalities: A Systematic Review and Meta-Analysis.
成人间质性肺异常的患病率、危险因素和结局:系统评价和荟萃分析。
Am J Respir Crit Care Med. 2023 Sep 15;208(6):695-708. doi: 10.1164/rccm.202302-0271OC.
4
Idiopathic pulmonary fibrosis in the United States: time to diagnosis and treatment.美国特发性肺纤维化:诊断和治疗的时机。
BMC Pulm Med. 2023 Aug 2;23(1):281. doi: 10.1186/s12890-023-02565-7.
5
An observational cohort study of interstitial lung abnormalities (ILAs) in a large Japanese health screening population (Kumamoto ILA study in Japan: KILA-J).一项针对日本大型健康筛查人群中肺间质异常(ILAs)的观察性队列研究(日本熊本 ILAs 研究:KILA-J)。
BMC Pulm Med. 2023 Jun 8;23(1):199. doi: 10.1186/s12890-023-02455-y.
6
Automated CT quantification of interstitial lung abnormality and interstitial lung disease according to the Fleischner Society in patients with resectable lung cancer: prognostic significance.基于 Fleischner 学会对可切除肺癌患者的肺间质异常和肺间质疾病的 CT 自动化定量分析:预后意义。
Eur Radiol. 2023 Nov;33(11):8251-8262. doi: 10.1007/s00330-023-09783-x. Epub 2023 Jun 2.
7
Prevalence and Long-term Outcomes of CT Interstitial Lung Abnormalities in a Health Screening Cohort.健康筛查队列中 CT 肺间质异常的患病率及长期预后。
Radiology. 2023 Feb;306(2):e221172. doi: 10.1148/radiol.221172. Epub 2022 Oct 11.
8
Interstitial Lung Abnormalities at CT: Subtypes, Clinical Significance, and Associations with Lung Cancer.CT 下的肺间质异常:亚型、临床意义及与肺癌的相关性。
Radiographics. 2022 Nov-Dec;42(7):1925-1939. doi: 10.1148/rg.220073. Epub 2022 Sep 9.
9
Diagnostic delay in IPF impacts progression-free survival, quality of life and hospitalisation rates.特发性肺纤维化(IPF)的诊断延迟会影响无进展生存期、生活质量和住院率。
BMJ Open Respir Res. 2022 Jul;9(1). doi: 10.1136/bmjresp-2022-001276.
10
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化(更新版)和成人进展性肺纤维化:美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2022 May 1;205(9):e18-e47. doi: 10.1164/rccm.202202-0399ST.